Round Type
Pre-Seed
WilmingtonBiotechnologyQuick answer
GENIE Therapeutics raised $50,000 in a Pre-Seed round, dated July 10, 2023. GENIE Therapeutics is based in Wilmington, Delaware, United States.
- How much did GENIE Therapeutics raise?
- GENIE Therapeutics raised $50,000 in a Pre-Seed round on July 10, 2023.
- What does GENIE Therapeutics do?
- GENIE Therapeutics is currently launching multiple gene therapies through the FDA pipeline.
- Where is GENIE Therapeutics based and how big is it?
- GENIE Therapeutics is based in Wilmington, Delaware, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as GENIE Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- WaveFront Dynamics Inc. raised $5M on August 24, 2023.
- ExcepGen raised an undisclosed amount (Funding Round) on August 24, 2023.
- Botanical Solutions raised $7M (Series A) on August 24, 2023.
- Rapport raised $150M (Series B) on August 24, 2023.
- Fore Biotherapeutics raised $75M (Series D) on August 24, 2023.
- Cellares raised $255M (Series C) on August 23, 2023.
Who to call at GENIE Therapeutics, and when
A new round usually means GENIE Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GENIE Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GENIE Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GENIE Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GENIE Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
GENIE Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.